Association between serum vitamin D level and response to antiviral therapy with peginterferon and ribavirin in patients with chronic hepatitis C.

Association between serum vitamin D level and response to antiviral therapy with peginterferon and ribavirin in patients with chronic hepatitis C. - Association between serum vitamin D level and response to antiviral therapy with peginterferon and ribavirin in patients with chronic hepatitis C.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003685

Enrollment

300

Registered

2010-06-02

Start date

2010-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic hepatitis C who underwent antiviral therapy with peginterferon and ribavirin and individuals for whom the clinical backgrounds were matched with patients with chronic hepatitis C (as controls).

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Comparison between pretreatment serum vitamin D level and treatment outcome.	—

Countries

Japan

Contacts

Public ContactRie Nishiwaki

Gifu University Graduate School of Medicine Department of Pharmacology

riemn@gifu-u.ac.jp058-230-6217

Outcome results